Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2
Aries C, Lohmöller B, Tiede S, Täuber K, Hartmann G, Rudolph C, Muschol N
FRONT NEUROL. 2022;13:907317.

Combination of high-dose ambroxol and ERT in Gaucher disease type 2: A nearly age-appropriate neurocognitive and motor development after three years of treatment
Aries C, Lohmöller B, Tiede S, Täuber K, Rudolph C, Muschol N
MOL GENET METAB. 2022;135(2):.

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
Ammer L, Pohl S, Breyer S, Aries C, Denecke J, Perez A, Petzoldt M, Schrum J, Müller I, Muschol N
MOL GENET METAB REP. 2021;26:.

Retinal vessel tortuosity as a prognostic marker for disease severity in Fabry disease
Atiskova Y, Wildner J, Spitzer M, Aries C, Muschol N, Dulz S
ORPHANET J RARE DIS. 2021;16(1):.

Letzte Aktualisierung aus dem FIS: 03.12.2024 - 03:34 Uhr